4 research outputs found

    Kinderliteratur im Fremdsprachenunterricht

    Get PDF

    Human Heading Perception Based on Form and Motion Combination

    Get PDF
    International audienceThis paper presents a study on human perception of the heading on the base of motion and form visual cues integration. The authors examine how human age influences this process. Because the visual stimuli are in general uncertain, or in some cases even conflicting, the process of combination is estimated on the base on the well known Normalized Conjunctive Consensus fusion rule, as well as on the base of the more efficient Dezert-Smarandache Theory (DSmT) of plausible and paradoxical reasoning, and more precisely on the probabilistic Proportional Conflict Redistribution rule no.5 defined within it. The main goal is focused on how these fusion rules succeed to model consistent and adequate predictions about both individuals' behavior, and age-contingent groups of individuals

    BONE RESORPTION MARKER BETA-CROSSLAPS FOR EARLY MONITORING OF OSTEOPOROSIS TREATMENT WITH DENOSUMAB

    Get PDF
    Antiresorptive long-term treatment for osteoporosis increases bone mineral density. Due to the long duration, poor compliance of patients to medication therapy is a big challenge. Bone mineral density measurements are recommended for the monitoring of treatment, but detectable changes may take up to 2-3 years. Bone turnover markers can indicate changes in bone turnover rates earlier, and assessment their levels may be effective in enhancing compliance and clinical efficacy. Purpose: Our study aimed to assess whether the dynamics in serum levels of bone resorption marker beta-CrossLaps have a real practical benefit for early monitoring of postmenopausal osteoporosis treatment. Materials and methods: 21 Bulgarian women in menopause with newly diagnosed osteoporosis were studied. All participants hadn’t been under treatment. Serum beta-CrossLaps levels were measured before and six months after subcutaneous administration of Denosumab – Injection 60 mg. Results: Serum concentrations before and six months after starting treatment were respectively 0.589 ± 0.266 ng/ml (0.06 – 1.2) and 0.166 ± 0.139 ng/ml (0.05 – 0.59). The beta-CrossLaps pre-treatment serum levels were within the reference range for the commercial kit used. After six months of treatment, there was a significant decrease in serum concentrations of about 72% from baseline. In our study, although pre-treatment levels were within the reference range, a significant decrease in concentrations was observed. Conclusions: The results show that the dynamics of beta-CrossLaps may be useful in the early monitoring of osteoporosis treatment

    Diffusion of sustainability innovation among Colorado ski resorts: a mixed methods approach

    No full text
    2016 Spring.Includes bibliographical references.To view the abstract, please see the full text of the document
    corecore